A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab

The purpose of this study is to explore the relationship between sarcopenia, as defined by computed tomography, treatment related outcomes and other body composition related parameters in a patient population receiving bevacizumab beyond progression.

本研究旨在探讨在疾病进展后仍接受贝伐珠单抗治疗的患者队列中，以计算机断层扫描（Computed Tomography）定义的肌少症与治疗相关结局及其他身体成分相关参数之间的关联。